Solutions for Safer ER/LA Opioid Prescribing in a New Era of Health Care Reform
On-demand Archives Track 1: Embracing New Models of Care Delivery that Lead to Safer ER/LA Opioid Prescribing Track 2: Implementing a Patient-Centric Approach for Safer ER/LA Opioid Prescribing Track 3: Leveraging Health Information Technology for Safer ER/LA Opioid Prescribing
Jointly provided by	This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with ER/LA Opioid Analgesics REMS education requirements issued by the US Food & Drug Administration.
DISTINGUISHED FACULTY PRESENTERS
Track 1: Embracing New Models of Care Delivery that Lead to Safer ER/LA Opioid Prescribing
Paul Grundy, MD, MPH IBM's Global Director of Healthcare Transformation President, Patient-Centered Primary Care Collaborative Joanna L. Starrels, MD, MS Associate Professor of Medicine Division of General Internal Medicine Albert Einstein College of Medicine & Montefiore Medical Center Melissa B. Weimer, DO, MCR Assistant Professor of Medicine Division of General Internal Medicine and Geriatrics Oregon Health & Science University
Track 2: Implementing a Patient-Centric Approach for Safer ER/LA Opioid Prescribing
William C. Becker, MD Assistant Professor of Medicine Yale School of Medicine Angela Golden, DNP, FNP-C, FAANP Family Nurse Practitioner NP from Home, LLC James B. Rickert, MD Clinical Assistant Professor Indiana University School of Medicine Orthopedic Surgeon Indiana University Health Southern Indiana Physicians
Track 3: Leveraging Health Information Technology for Safer ER/LA Opioid Prescribing
Christopher Harle, PhD Associate Professor, Health Policy and Management Richard M. Fairbanks School of Public Health Indiana University Purdue University, Indianapolis Affiliated Scientist, Regenstrief Institute David K. Nace, MD Chief Medical Officer MarkLogic Corporation Board Member Patient-Centered Primary Care Collaborative
TARGET AUDIENCE
The primary target audience consists of physicians, physician assistants, and nurse practitioners who currently prescribe ER/LA opioids in managed care organizations, integrated delivery systems, and Accountable Care Organizations/Patient-Centered Medical Home (ACO/PCMH) care settings. The secondary audience includes physicians, physician assistants, and nurse practitioners who have not prescribed opioids in the past 12 months but who may in the future or who are responsible for policy/procedure development in these settings, as well as the vast number of ancillary health care professionals associated with appropriate selection and monitoring of opioid therapy including registered nurses, pharmacists, medical assistants, and pharmacy technicians.
STATEMENT OF EDUCATIONAL NEED
The core of new accountable care ecosystem is patient-centered primary care, a model where the relationship between the provider and the patient ensures that appropriate care is structured, delivered, and coordinated around the specific needs of the patient. New care models hold tremendous promise for implementing the REMS FDA Blueprint education as a result of incentivized coordination and collaboration among various care givers. Emerging care models can improve patient care transitions that result from system failures in the transition from various health care settings and providers. Clinicians will receive information that will allow them to improve their ability to: provide safer treatment to extended-release/long-acting (ER/LA) opioid patient populations, track and coordinate referrals, provide appropriate access and communication, plan and manage care, and measure performance improvement.
GOALS OF PROGRAM
Educate participants on the FDA's REMS Blueprint Core Content while also addressing clinicians' educational needs in evaluating new care models, identifying best practices, and implementing solutions for advancing community-based collaboration in order to improve outcomes for patients on ER/LA opioid therapy.
LEARNING OBJECTIVES
Track 1: (Includes FDA Blueprint elements I and II) Describe current guidelines for treatment with ER/LA opioids and opportunities to integrate such guidelines into new models of care delivery List quality indicators impacted by non-adherence to national guidelines regarding treatment with ER/LA opioids Track 2: (Includes FDA Blueprint elements IV, V, and VI) Discuss the importance of shared decision-making and patient education for patients who need or are receiving ER/LA opioids Employ 2 patterns of communication that can improve patient/provider communication around ER/LA opioid therapy Track 3: (Includes FDA Blueprint elements I, II, and III) Use the EHR to improve the management of patients taking ER/LA opioids and reduce the opportunity for diversion and abuse Describe the benefits of using a state PDMP in improving management of patients receiving ER/LA opioids and reducing the risk of addiction, misuse, and diversion Integrate the state PDMP into the practice's EHR to reduce misuse and diversion
ACCREDITATION INFORMATION
Credit Available Physicians - maximum of 4.5 AMA PRA Category 1 CreditsTM Nurses - 4.5 Nursing Contact Hours Completion of all 3 learning tracks is needed to receive up to 4.5 credit hours. Activities are REMS-compliant and upon the successful completion of the following steps, participants will receive a REMS certificate of completion suitable for framing: Complete all 3 learning tracks either by successful completion of the live webcasts held December 2015-February 2016, the enduring web archives, or a mix of both the live and enduring activities. Successfully complete post-tests with a score of 75% or better for all 3 learning tracks Complete evaluation forms for all 3 learning tracks Your participation and successful completion of the activities will be tracked for you All other healthcare professionals completing this course will be issued a statement of participation. Accreditation Statement Physician Continuing Medical Education Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this 3-part enduring activity for a maximum of 4.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Continuing Education Credit Designation This 3-part educational activity for 4.5 contact hours is provided by Postgraduate Institute for Medicine. Accreditation Statement Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Questions Contact info@impactedu.net with any questions.